Cargando…
Short‐term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE‐1)
AIM: To evaluate the feasibility and safety of total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer (LARC) in Japan. METHODS: This prospective, multicenter, open‐label, single‐arm phase II trial was conducted at five institutions. The key eligibility criteria were age ≥ 20...
Autores principales: | Kagawa, Yoshinori, Watanabe, Jun, Uemura, Mamoru, Ando, Koji, Inoue, Akira, Oba, Koji, Takemasa, Ichiro, Oki, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623965/ https://www.ncbi.nlm.nih.gov/pubmed/37927927 http://dx.doi.org/10.1002/ags3.12715 |
Ejemplares similares
-
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
por: Matsuda, Chu, et al.
Publicado: (2022) -
Treatment response prediction of neoadjuvant chemotherapy for rectal cancer by deep learning of colonoscopy images
por: Kato, Shinya, et al.
Publicado: (2023) -
Clinical impact of the triple‐layered circular stapler for reducing the anastomotic leakage in rectal cancer surgery: Porcine model and multicenter retrospective cohort analysis
por: Nakanishi, Ryota, et al.
Publicado: (2021) -
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018) -
A Case of Panitumumab-Responsive Metastatic Rectal Cancer Initially Refractory to Cetuximab
por: Kasagi, Yuta, et al.
Publicado: (2013)